BioWorld

April 14, 2008

View Archived Issues

PDL to Spin Off Biotech Assets into New Firm by End of Year

Nearly a month after taking steps to streamline the company, PDL BioPharma Inc. said it plans to spin off its biotechnology assets into a separate publicly traded firm. (BioWorld Today) Read More

Lung Cancer Phase III Trial Garners Antisoma $25M

Read More

Lower-Than-Expected Avastin Sales Mar Genentech's lst Quarter

Read More

NewCo News: Molecular LogiX Plans to Use (Dominant) Negativity for Good

Read More

Clinic Roundup

Read More

Other News To Note

Read More